Optimization of PVA Concentration and Receiver Phase Volume in the Preparation of Rutin Microparticles
Microparticles, which range in size from 1 to 1000 micrometers, are used as multiunit drug delivery systems with well-defined physiological and pharmacokinetic benefits in order to improve efficacy, tolerance, and patient compliance [5]. Results & Discussion This research is an experimental stud...
Saved in:
Published in | Journal of pharmaceutical sciences and research Vol. 13; no. 10; pp. 615 - 616 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Cuddalore
Journal of Pharmaceutical Sciences and Research
01.10.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Microparticles, which range in size from 1 to 1000 micrometers, are used as multiunit drug delivery systems with well-defined physiological and pharmacokinetic benefits in order to improve efficacy, tolerance, and patient compliance [5]. Results & Discussion This research is an experimental study to provide an overview of optimization in the manufacture of microparticles. Because of its potential benefits such as enhanced bioavailability, reduced risk of systemic toxicity, reduced risk of local irritation, and predictable gastric emptying, microparticulate drug delivery system has recently received a lot of attention in comparison to single unit systems [7]. Ethanol was used as a cosolvent to dissolve rutin. while the addition of dichloromethane will help the solvent evaporation process run faster to produce microparticles. References [1] B. Gullón, T. A. Lú-Chau, M. T. Moreira, J. M. Lema, and G. Eibes, "Rutin: A review on extraction, identification and purification methods, biological activities and approaches to enhance its bioavailability," Trends in Food Science & Technology, vol. 67, pp. 220-235, Sep. 2017, doi: 10.1016/j.tifs.2017.07.008. |
---|---|
ISSN: | 0975-1459 |